Accuracy of Velacur in Assessing MASLD and MASH Patients Using Biopsy as the Gold Standard
Accuracy of Velacur in Assessing MASLD and MASH Patients Using Biopsy as the Gold Standard
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
: Velacur
is a novel, point-of-care ultrasound device developed to accurately diagnose patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH). The Velacur system non-invasively assesses liver stiffness, attenuation, and the Velacurdetermined fat fraction (VDFF)....
Alternative Titles
Full title
Accuracy of Velacur in Assessing MASLD and MASH Patients Using Biopsy as the Gold Standard
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4b55c230caa84ca89db005ed6ec28786
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4b55c230caa84ca89db005ed6ec28786
Other Identifiers
ISSN
2075-4418
E-ISSN
2075-4418
DOI
10.3390/diagnostics15050615
